327 results on '"Trama Annalisa"'
Search Results
2. Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working group
3. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study
4. Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group
5. Survival of European adolescents and young adults diagnosed with cancer in 2010–2014
6. Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
7. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
8. Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities
9. Incidence and prognosis of Cutaneous Melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results
10. HeNeCOn: An ontology for integrative research in Head and Neck cancer
11. Solutions for optimal care and research for children and adolescents with extremely rare cancers developed within the Joint Action for Rare Cancers (JARC)
12. Epidemiology of rare cancers in India and South Asian countries – remembering the forgotten
13. Increased incidence of rare cancers and varied age distributions by cancer group: A population-based cancer registry study in Hiroshima Prefecture, Japan
14. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study
15. From Real-World Data to Causally Interpretable Models: A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast Cancer.
16. Being diagnosed with a rhabdomyosarcoma in the era of artificial intelligence: Whom can we trust?
17. Oral cancer in young adults: incidence, risk factors, prognosis, and molecular biomarkers.
18. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
19. Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet)
20. Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet)
21. Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia
22. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
23. Priorities on rare cancers’ policy in National Cancer Control Plans (NCCPs): A review conducted within the framework of EU-JARC Joint-Action
24. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU)
25. Changes in life expectancy for cancer patients over time since diagnosis
26. The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma
27. Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes
28. Cancer of the anal region
29. Treatment challenges in and outside a network setting: Head and neck cancers
30. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference
31. Networking in rare cancers: What was done, what's next
32. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
33. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
34. Epidemiology of rare cancers and inequalities in oncologic outcomes
35. Treatment challenges in and outside a network setting: Soft tissue sarcomas
36. Survival of adults with cancers of bone or soft tissue in Europe—Report from the EUROCARE-5 study
37. Bayesian estimates of the incidence of rare cancers in Europe
38. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
39. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
40. Improving treatment results with reference centres for rare cancers: where do we stand?
41. Resolution of Citalopram Sexual Adverse Effects With Low Dose of Cariprazine: A Case Report
42. Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study
43. Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5
44. Diagnosis and management of typical and atypical lung carcinoids
45. Thymoma and thymic carcinomas
46. The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers : The protocol for the rare head and neck cancers
47. EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report
48. Chordoma: update on disease, epidemiology, biology and medical therapies
49. Big Data in Head and Neck Cancer
50. Cancer treatment data available in European cancer registries: Where are we and where are we going?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.